Navigation

  • Skip to Content
NTNU Home NTNU Home

ntnu.edu

  • Studies
    • Master's programmes in English
    • For exchange students
    • PhD opportunities
    • All programmes of study
    • Courses
    • Financing
    • Language requirements
    • Application process
    • Academic calendar
    • FAQ
  • Research and innovation
    • NTNU research
    • Research excellence
    • Strategic research areas
    • Innovation resources
    • PhD opportunities
  • Life and housing
    • Student in Trondheim
    • Student in Gjøvik
    • Student in Ålesund
    • For researchers
    • Life and housing
  • About NTNU
    • Contact us
    • Faculties and departments
    • Libraries
    • International researcher support
    • Vacancies
    • About NTNU
    • Maps
  1. Employees

Språkvelger

Norsk

Mari Nordbø Gynnild

Download press photo
Download press photo
Foto:

Mari Nordbø Gynnild

Postdoctoral researcher
Department of Circulation and Medical Imaging

mari.nordbo.gynnild@ntnu.no
AHL-senteret, Øya, Prinsesse Kristinas gt 3
Twitter ResearchGate AG Preventiv Young Ambassador EAPC
About Research Publications Outreach

About

Mari Nordbø Gynnild is a resident physician specializing in internal medicine and cardiology at the Clinic of Cardiology, St. Olavs Hospital, and a researcher at the K.G. Jebsen Center for Cardiac Biomarkers, Institute of Clinical Medicine, University of Oslo.

She earned her medical degree from NTNU (2013) and holds a PhD from NTNU (2022) in collaboration with the University Medical Center Utrecht, focusing on adherence to pharmacological secondary prevention and how to predict the risk of future cardiovascular events.

Her research includes risk assessment and prevention of cardiovascular disease, cardio-oncology, and echocardiography. She is a postdoctoral fellow in the randomized PRADA II study, which investigates whether the heartfailure medication sacubitril/valsartan can prevent cardiac injury in breast cancer patients undergoing chemotherapy. She is the project leader of the study "Risk prediction for individualized cardiovascular disease prevention" (REK 590420) and collaborates internationally to test and improve models that predict the risk of cardiovascular disease.

Competencies

  • Adherence
  • Anticoagulation
  • Cardiovascular Diseases
  • Cardiovascular disease
  • Cardiovascular medicine
  • Cerebral stroke
  • Compliance
  • Hjertesvikt
  • Hypertension
  • Kardioonkologi
  • Pharmacology

Research

PRevention of cArdiac Dysfunction during Adjuvant breast cancer therapy (PRADA II) trial

A randomized, placebo-controlled, multicenter trial assessing if sacubitril/valsartan given concomitantly with early breast cancer treatment regimens including anthracyclines, with or without trastuzumab, may prevent cardiac dysfunction.

Risk prediction for individualized cardiovascular disease prevention

This project aims to externally validate and compare guideline-recommended cardiovascular risk prediction tools, as well as tailor models to local settings, new settings and investigate whether these models can be extended by addition of new predictors.

Publications

  • Chronological
  • By category
  • All publications registered in NVA

2026

  • Holtrop, Joris; Gynnild, Mari Nordbø; Deo, Salil V; Lim, Carl-Emil; Logothetis, Stelios Boulitsakis; Läll, Kristi; Oksanen, Minna; Dalen, Håvard; Munkhaugen, John; Ueda, Peter. (2026) Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model. European Heart Journal
    Academic article
  • Omland, Torbjørn; Heck, Siri Lagethon; Holte, Espen; Gynnild, Mari Nordbø; Gulati, Geeta; Wethal, Torgeir. (2026) Response by Omland et al to Letter Regarding Article, “Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial”. Circulation
    Academic article
  • Kaptoge, Stephen; Keene, Spencer J; Reitsma, Tessa; Shi, Wen; Lees, Jennifer S; Lõo, Laura; Gynnild, Mari Nordbø; Chilala, Chimweta; Ritchie, Scott; Spackman, Sarah. (2026) Prediction of incident heart failure in individuals without prior cardiovascular disease: the SCORE2-HF risk model. European Heart Journal
    Academic article
  • Reitsma, Tessa H; Lim, Carl-Emil; Gynnild, Mari Nordbø; Kaptoge, Stephen; Lõo, Laura; Holtrop, Joris; Kuźma, Łukasz; Pennells, Lisa; Conrad, Nathalie; Ueda, Peter. (2026) Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model. European Heart Journal
    Academic article
  • Holtrop, Joris; Gynnild, Mari N; Richards, Matthew; Lim, Carl-Emil; Lääperi, Mitja; Deo, Salil V; Dalen, Håvard; Ueda, Peter; Rajagopalan, Sanjay; Chlabicz, Małgorzata. (2026) Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk score. European Journal of Preventive Cardiology (EJPC)
    Academic article

2025

  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven H J; Vinje, Victoria; Dorresteijn, Jannick A N; Visseren, Frank L J; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2025) External validation of the systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in cancer patients. European Journal of Preventive Cardiology (EJPC)
    Academic article
  • Gynnild, Mari Nordbø; Vinje-Jakobsen, Victoria; Holtrop, Joris; Hageman, Steven H.J.; Holte, Espen; Gulati, Geeta; Heck, Siri Lagethon; Dorresteijn, Jannick A.N.; Visseren, Frank L.J.; Fagerli, Unn Merete. (2025) Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients. JACC: Advances
    Academic article
  • Hageman, Steven H J; Kaptoge, Stephen; Gynnild, Mari Nordbø; Holtrop, Joris; Pennells, Lisa; McEvoy, J William; Bobak, Martin; Pająk, Andrzej; Pikhart, Hynek; Tamosiunas, Abdonas. (2025) Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention. European Heart Journal - Quality of Care and Clinical Outcomes
    Academic article
  • Gynnild, Mari Nordbø; Hageman, Steven; Holtrop, Joris; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2025) Improved risk stratification with SCORE2 on top of HFA-ICOS in cancer patients without previous cardiovascular disease. European Heart Journal, Supplement
    Professional article
  • Holtrop, Joris; Gynnild, Mari Nordbø; Dammen, Toril; Dalen, Håvard; Saltvedt, Ingvild Tina; Ellekjær, Hanne; Hageman, Steven H J; Visseren, Frank L J; McEvoy, John William; Dorresteijn, Jannick A N. (2025) Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients. European Journal of Preventive Cardiology (EJPC)
    Academic article
  • Omland, Torbjørn; Heck, Siri Lagethon; Holte, Espen; Mecinaj, Albulena; Gynnild, Mari Nordbø; Fagerland, Morten; Vinje, Victoria; Næs, Anne-Katrine Lislegaard; Blix, Egil Støre; Larsen, Alf Inge. (2025) Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial. Circulation
    Academic article
  • Sande, Ingvild Svorkdal; Helgheim, Kamilla Lind; Saltvedt, Ingvild Tina; Røsstad, Tove Garåsen; Spigset, Olav; Ellekjær, Hanne; Gynnild, Mari Nordbø. (2025) Follow-Up in Primary Care After Ischemic Stroke - Insights From the Nor-COAST Study. International Journal of General Medicine
    Academic article
  • Fagerli, Erlend; Ellekjær, Hanne; Spigset, Olav; Saltvedt, Ingvild Tina; Gynnild, Mari Nordbø. (2025) Three-year adherence to secondary prevention and vascular risk control after ischemic stroke. European Stroke Journal
    Academic article
  • Hageman, Steven HJ; Kaptoge, Steven; Gynnild, Mari Nordbø; Pennels, Lisa; Pajak, Andrzej; Pikhart, Hynek; Mach, Francois; Smulders, Yvo M.; Carballo, David; Angelantonio, Emanuele Di. (2025) Assessment of CV risk by SCORE2 with an online calculator estimates CV risk better compared to 2-dimensional risk charts. European Journal of Preventive Cardiology (EJPC)
    Professional article
  • Holtrop, Joris; Gynnild, Mari Nordbø; Dammen, Toril; Dalen, Håvard; Hageman, Steven HJ; Visseren, Frank; McEvoy, John William; Dorresteijn, Jannick; Munkhaugen, John. (2025) Integration of psychological risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with atherosclerotic cardiovascular disease. European Journal of Preventive Cardiology (EJPC)
    Professional article
  • Gynnild, Mari Nordbø; Holtrop, Joris; Dalen, Håvard; Dorresteijn, Jannick; Visseren, Frank; Holte, Espen; Omland, Torbjørn; Wethal, Torgeir; Hageman, Steven HJ. (2025) Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors. European Journal of Preventive Cardiology (EJPC)
    Conference abstract

2024

  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven HJ; Vinje, Victoria; Dorresteijn, Jannick AN; Visseren, Frank; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2024) External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment. European Heart Journal, Supplement
    Conference abstract
  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven HJ; Vinje, Victoria; Dorresteijn, Jannick AN; Visseren, Frank; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2024) External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients. European Heart Journal, Supplement
    Conference abstract
  • Gynnild, Mari Nordbø. (2024) Kardiovaskulær risikostratifisering. Hjerteforum
    Commentary
  • Holtrop, Joris; Gynnild, Mari Nordbø; Munkhaugen, John; Dalen, Håvard; Lim, Carl-Emil; Ueda, Peter; Jernberg, Thomas; Tuñón, José; Chlabicz, Małgorzata; Steg, Philippe Gabriel. (2024) Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model. European Heart Journal, Supplement
    Conference abstract

2023

  • Aakerøy, Rachel; Gynnild, Mari Nordbø; Løfblad, Lena; Dyrkorn, Roar; Ellekjær, Hanne; Lydersen, Stian; Helland, Arne; Spigset, Olav. (2023) Direct oral anticoagulant concentrations and adherence in stroke patients. Basic & Clinical Pharmacology & Toxicology
    Academic article

2022

  • Gynnild, Mari Nordbø; Ellekjær, Hanne; Spigset, Olav; Røsstad, Tove; Næss, Halvor. (2022) RESIDUAL CARDIOVASCULAR RISK AFTER ISCHEMIC STROKE Risk factors, medication adherence and risk-benefit considerations. Norges teknisk-naturvitenskapelige universitet
    Doctoral thesis
  • Hageman, Steven HJ; McKay, Ailsa; Ueda, Peter; Gunn, Laura; Jernberg, Tomas; Hagström, Emil; Bhatt, Deepak L.; Läll, Kristi; Steg, Philippe Gabriel; Mägi, Reddik. (2022) Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: The updated SMART2 algorithm. European Heart Journal
    Academic article
  • Gynnild, Mari Nordbø; Hageman, Steven H. J.; Spigset, Olav; Lydersen, Stian; Saltvedt, Ingvild; Dorresteijn, Jannick AN; Visseren, Frank L.J.; Ellekjær, Hanne. (2022) Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment. Open heart
    Academic article

2021

  • Gynnild, Mari Nordbø; Hageman, Steven HJ; Dorresteijn, Jannick AN; Spigset, Olav; Lydersen, Stian; Wethal, Torgeir; Saltvedt, Ingvild; Visseren, Frank LJ; Ellekjær, Hanne. (2021) Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention. Clinical Epidemiology
    Academic article
  • Aam, Stina; Gynnild, Mari Nordbø; Munthe-Kaas, Ragnhild; Saltvedt, Ingvild; Lydersen, Stian; Knapskog, Anne Brita; Ihle-Hansen, Hege; Ellekjær, Hanne; Eldholm, Rannveig Sakshaug; Fure, Brynjar. (2021) The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study. Frontiers in Neurology
    Academic article

2020

  • Gynnild, Mari Nordbø; Aakerøy, Rachel; Spigset, Olav; Askim, Torunn; Beyer, Mona Kristiansen; Ihle-Hansen, Hege; Munthe-Kaas, Ragnhild; Knapskog, Anne Brita; Lydersen, Stian; Næss, Halvor. (2020) Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke. Journal of Internal Medicine
    Academic article

2014

  • Anshushaug, Malin; Gynnild, Mari Aas; Kaasa, Stein; Kvikstad, Anne; Grønberg, Bjørn H.. (2014) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncologica
    Academic article

Journal publications

  • Holtrop, Joris; Gynnild, Mari Nordbø; Deo, Salil V; Lim, Carl-Emil; Logothetis, Stelios Boulitsakis; Läll, Kristi; Oksanen, Minna; Dalen, Håvard; Munkhaugen, John; Ueda, Peter. (2026) Predicting lifetime cardiovascular risk and benefits of preventive treatment in patients with established atherosclerotic cardiovascular disease: the SMART-REACH2 model. European Heart Journal
    Academic article
  • Omland, Torbjørn; Heck, Siri Lagethon; Holte, Espen; Gynnild, Mari Nordbø; Gulati, Geeta; Wethal, Torgeir. (2026) Response by Omland et al to Letter Regarding Article, “Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial”. Circulation
    Academic article
  • Kaptoge, Stephen; Keene, Spencer J; Reitsma, Tessa; Shi, Wen; Lees, Jennifer S; Lõo, Laura; Gynnild, Mari Nordbø; Chilala, Chimweta; Ritchie, Scott; Spackman, Sarah. (2026) Prediction of incident heart failure in individuals without prior cardiovascular disease: the SCORE2-HF risk model. European Heart Journal
    Academic article
  • Reitsma, Tessa H; Lim, Carl-Emil; Gynnild, Mari Nordbø; Kaptoge, Stephen; Lõo, Laura; Holtrop, Joris; Kuźma, Łukasz; Pennells, Lisa; Conrad, Nathalie; Ueda, Peter. (2026) Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model. European Heart Journal
    Academic article
  • Holtrop, Joris; Gynnild, Mari N; Richards, Matthew; Lim, Carl-Emil; Lääperi, Mitja; Deo, Salil V; Dalen, Håvard; Ueda, Peter; Rajagopalan, Sanjay; Chlabicz, Małgorzata. (2026) Improving 10-year cardiovascular risk prediction in patients with established cardiovascular disease: flexible addition of risk predictors on top of the SMART2 risk score. European Journal of Preventive Cardiology (EJPC)
    Academic article
  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven H J; Vinje, Victoria; Dorresteijn, Jannick A N; Visseren, Frank L J; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2025) External validation of the systematic coronary risk evaluation 2 (SCORE2) and SCORE2-older persons in cancer patients. European Journal of Preventive Cardiology (EJPC)
    Academic article
  • Gynnild, Mari Nordbø; Vinje-Jakobsen, Victoria; Holtrop, Joris; Hageman, Steven H.J.; Holte, Espen; Gulati, Geeta; Heck, Siri Lagethon; Dorresteijn, Jannick A.N.; Visseren, Frank L.J.; Fagerli, Unn Merete. (2025) Prognostic Performance of a Modified HFA-ICOS Tool for Prediction of Cardiovascular Complications in Cancer Patients. JACC: Advances
    Academic article
  • Hageman, Steven H J; Kaptoge, Stephen; Gynnild, Mari Nordbø; Holtrop, Joris; Pennells, Lisa; McEvoy, J William; Bobak, Martin; Pająk, Andrzej; Pikhart, Hynek; Tamosiunas, Abdonas. (2025) Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention. European Heart Journal - Quality of Care and Clinical Outcomes
    Academic article
  • Gynnild, Mari Nordbø; Hageman, Steven; Holtrop, Joris; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2025) Improved risk stratification with SCORE2 on top of HFA-ICOS in cancer patients without previous cardiovascular disease. European Heart Journal, Supplement
    Professional article
  • Holtrop, Joris; Gynnild, Mari Nordbø; Dammen, Toril; Dalen, Håvard; Saltvedt, Ingvild Tina; Ellekjær, Hanne; Hageman, Steven H J; Visseren, Frank L J; McEvoy, John William; Dorresteijn, Jannick A N. (2025) Psychological factors beyond the SMART2 model for predicting recurrent events in atherosclerotic cardiovascular disease patients. European Journal of Preventive Cardiology (EJPC)
    Academic article
  • Omland, Torbjørn; Heck, Siri Lagethon; Holte, Espen; Mecinaj, Albulena; Gynnild, Mari Nordbø; Fagerland, Morten; Vinje, Victoria; Næs, Anne-Katrine Lislegaard; Blix, Egil Støre; Larsen, Alf Inge. (2025) Sacubitril/Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial. Circulation
    Academic article
  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven HJ; Vinje, Victoria; Dorresteijn, Jannick AN; Visseren, Frank; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2024) External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment. European Heart Journal, Supplement
    Conference abstract
  • Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven HJ; Vinje, Victoria; Dorresteijn, Jannick AN; Visseren, Frank; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2024) External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients. European Heart Journal, Supplement
    Conference abstract
  • Gynnild, Mari Nordbø; Aakerøy, Rachel; Spigset, Olav; Askim, Torunn; Beyer, Mona Kristiansen; Ihle-Hansen, Hege; Munthe-Kaas, Ragnhild; Knapskog, Anne Brita; Lydersen, Stian; Næss, Halvor. (2020) Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke. Journal of Internal Medicine
    Academic article
  • Sande, Ingvild Svorkdal; Helgheim, Kamilla Lind; Saltvedt, Ingvild Tina; Røsstad, Tove Garåsen; Spigset, Olav; Ellekjær, Hanne; Gynnild, Mari Nordbø. (2025) Follow-Up in Primary Care After Ischemic Stroke - Insights From the Nor-COAST Study. International Journal of General Medicine
    Academic article
  • Aakerøy, Rachel; Gynnild, Mari Nordbø; Løfblad, Lena; Dyrkorn, Roar; Ellekjær, Hanne; Lydersen, Stian; Helland, Arne; Spigset, Olav. (2023) Direct oral anticoagulant concentrations and adherence in stroke patients. Basic & Clinical Pharmacology & Toxicology
    Academic article
  • Fagerli, Erlend; Ellekjær, Hanne; Spigset, Olav; Saltvedt, Ingvild Tina; Gynnild, Mari Nordbø. (2025) Three-year adherence to secondary prevention and vascular risk control after ischemic stroke. European Stroke Journal
    Academic article
  • Anshushaug, Malin; Gynnild, Mari Aas; Kaasa, Stein; Kvikstad, Anne; Grønberg, Bjørn H.. (2014) Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway. Acta Oncologica
    Academic article
  • Gynnild, Mari Nordbø; Hageman, Steven HJ; Dorresteijn, Jannick AN; Spigset, Olav; Lydersen, Stian; Wethal, Torgeir; Saltvedt, Ingvild; Visseren, Frank LJ; Ellekjær, Hanne. (2021) Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention. Clinical Epidemiology
    Academic article
  • Hageman, Steven HJ; Kaptoge, Steven; Gynnild, Mari Nordbø; Pennels, Lisa; Pajak, Andrzej; Pikhart, Hynek; Mach, Francois; Smulders, Yvo M.; Carballo, David; Angelantonio, Emanuele Di. (2025) Assessment of CV risk by SCORE2 with an online calculator estimates CV risk better compared to 2-dimensional risk charts. European Journal of Preventive Cardiology (EJPC)
    Professional article
  • Holtrop, Joris; Gynnild, Mari Nordbø; Dammen, Toril; Dalen, Håvard; Hageman, Steven HJ; Visseren, Frank; McEvoy, John William; Dorresteijn, Jannick; Munkhaugen, John. (2025) Integration of psychological risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with atherosclerotic cardiovascular disease. European Journal of Preventive Cardiology (EJPC)
    Professional article
  • Gynnild, Mari Nordbø; Holtrop, Joris; Dalen, Håvard; Dorresteijn, Jannick; Visseren, Frank; Holte, Espen; Omland, Torbjørn; Wethal, Torgeir; Hageman, Steven HJ. (2025) Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors. European Journal of Preventive Cardiology (EJPC)
    Conference abstract
  • Gynnild, Mari Nordbø. (2024) Kardiovaskulær risikostratifisering. Hjerteforum
    Commentary
  • Aam, Stina; Gynnild, Mari Nordbø; Munthe-Kaas, Ragnhild; Saltvedt, Ingvild; Lydersen, Stian; Knapskog, Anne Brita; Ihle-Hansen, Hege; Ellekjær, Hanne; Eldholm, Rannveig Sakshaug; Fure, Brynjar. (2021) The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST Study. Frontiers in Neurology
    Academic article
  • Hageman, Steven HJ; McKay, Ailsa; Ueda, Peter; Gunn, Laura; Jernberg, Tomas; Hagström, Emil; Bhatt, Deepak L.; Läll, Kristi; Steg, Philippe Gabriel; Mägi, Reddik. (2022) Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: The updated SMART2 algorithm. European Heart Journal
    Academic article
  • Gynnild, Mari Nordbø; Hageman, Steven H. J.; Spigset, Olav; Lydersen, Stian; Saltvedt, Ingvild; Dorresteijn, Jannick AN; Visseren, Frank L.J.; Ellekjær, Hanne. (2022) Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment. Open heart
    Academic article
  • Holtrop, Joris; Gynnild, Mari Nordbø; Munkhaugen, John; Dalen, Håvard; Lim, Carl-Emil; Ueda, Peter; Jernberg, Thomas; Tuñón, José; Chlabicz, Małgorzata; Steg, Philippe Gabriel. (2024) Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model. European Heart Journal, Supplement
    Conference abstract

Student thesis or dissertation

  • Gynnild, Mari Nordbø; Ellekjær, Hanne; Spigset, Olav; Røsstad, Tove; Næss, Halvor. (2022) RESIDUAL CARDIOVASCULAR RISK AFTER ISCHEMIC STROKE Risk factors, medication adherence and risk-benefit considerations. Norges teknisk-naturvitenskapelige universitet
    Doctoral thesis

Outreach

2025

  • Conference lecture
    Reitsma, Tessa; Holtrop, Joris; Gynnild, Mari Nordbø; Lim, Carl E; Pennels, Lisa; Keene, Spencer; Jernberg, Thomas; Bhatt, Deepak; Boer, R A De; Wood, Angela. (2025) Lifetime prediction of incident heart failure risk in patients with established atherosclerotic cardiovascular disease: the SMART2-HF risk score. ESC Congress Madrid 2025
  • Conference lecture
    Gynnild, Mari Nordbø; Hageman, Steven; Holtrop, Joris; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2025) Improved risk stratification with SCORE2 on top of HFA-ICOS in cancer patients without previous cardiovascular disease. ESC Congress Madrid 2025
  • Conference lecture
    Hageman, Steven H. J.; Kaptoge, Stephen; Gynnild, Mari Nordbø; Holtrop, Joris; Pennels, Lisa; McEvoy, John William; Bobak, Martin; Pajak, Andrzej; Pikhart, Hynek; Tamosiunas, Abdonas. (2025) Using SCORE2 with a risk chart or online calculator: Impact on model performance, treatment eligibility and cardiovascular disease prevention. ESC Preventive Cardiology 2025
  • Conference lecture
    Gynnild, Mari Nordbø; Holtrop, Joris; Dorresteijn, Jannick A. N.; Visseren, F.L.J.; Dalen, Håvard; Holte, Espen; Wethal, Torgeir; Omland, Torbjørn; Hageman, Steven H. J.. (2025) Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors. ESC Preventive Cardiology 2025
  • Conference lecture
    Holtrop, Joris; Gynnild, Mari Nordbø; Dalen, Håvard; Dammen, Toril; McEvoy, John William; Hageman, Steven H. J.; Visseren, Frank; Munkhaugen, John; Dorresteijn, Jannick A. N.. (2025) Integration of guideline-recommended psychosocial risk modifiers on-top the SMART2-risk score for estimation of recurrent cardiovascular events in patients with established cardiovascular disease. ESC Preventive Cardiology 2025

2024

  • Conference lecture
    Holtrop, Joris; Gynnild, Mari Nordbø; Ueda, Peter; Tuñón, José; Bhat, Deepak; Jernberg, Thomas; Visseren, Frank; Dorresteijn, Jannick A.N.; Hageman, Steven HJ. (2024) Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model. ESC Congress London
  • Conference lecture
    Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven; Vinje, Victoria; Dorresteijn, Jannick; Visseren, Frank; Holte, Espen; Dalen, Håvard; Wethal, Torgeir; Omland, Torbjørn. (2024) External validation of the Systematic COronary Risk Evaluation 2 (SCORE2) model in cancer patients. ESC Congress London
  • Conference lecture
    Gynnild, Mari Nordbø; Holtrop, Joris; Hageman, Steven; Vinje, Victoria; Dorresteijn, Jannick A.N.; Visseren, Frank; Dalen, Håvard; Holte, Espen; Omland, Torbjørn; Wethal, Torgeir. (2024) External validation of the HFA-ICOS risk stratification tool for prediction of cardiovascular complications after cancer treatment. ESC Congress London

2022

  • Lecture
    Gynnild, Mari Nordbø. (2022) Etterlevelse av forbyggende behandling, er vi sammen gode nok?. Geriatrikongressen
  • Interview
    Gynnild, Mari Nordbø. (2022) Under halvparten nådde de anbefalte målene for blodtrykk og kolesterol.

2021

  • Lecture
    Gynnild, Mari Nordbø. (2021) Optimalisert etterlevelse for sekundærprofylaktiske legemidler. Bergenskonferansen, Norsk hjerneslagforening

2020

  • Conference poster
    Gynnild, Mari Nordbø; Aakerøy, Rachel; Spigset, Olav; Ellekjær, Hanne. (2020) Adherence to secondary preventive anticoagulation and risk for subsequent stroke and death. European Stroke Organisation and World Stroke Organization (ESO-WSO 2020) Virtual Conference

2018

  • Conference poster
    Gynnild, Mari Nordbø; Ellekjær, Hanne. (2018) Adherence to secondary prevention after stroke. European Stroke Organisation Conference (ESOC)

NTNU – Norwegian University of Science and Technology

  • For employees
  • |
  • For students
  • |
  • Intranet
  • |
  • Canvas

Studies

  • Master's programmes in English
  • For exchange students
  • PhD opportunities
  • Courses
  • Career development
  • Continuing education
  • Application process

News

  • NTNU News
  • Vacancies

About NTNU

  • About the university
  • Libraries
  • NTNU's strategy
  • Research excellence
  • Strategic research areas
  • Organizational chart

Contact

  • Contact NTNU
  • Employees
  • Find experts
  • Press contacts
  • Researcher support
  • Maps

NTNU in three cities

  • NTNU in Gjøvik
  • NTNU in Trondheim
  • NTNU in Ålesund

About this website

  • Use of cookies
  • Accessibility statement
  • Privacy policy
  • Editorial responsibility
Facebook Instagram Linkedin Snapchat Tiktok Youtube
Sign In
NTNU logo